Contracting human skeletal muscle maintains the ability to blunt α1-adrenergic vasoconstriction during KIR channel and Na+/K+-ATPase inhibition

Journal of Physiology

Volumn 593, Issue 12, 2015, Pages 2735-2751

  Crecelius, Anne R ^a   Kirby, Brett S ^a   Hearon, Christopher M ^a   Luckasen, Gary J ^b   Larson, Dennis G ^b   Dinenno, Frank A ^a  

^a Veterinary Dentistry and Oral Surgery   (United States)

^b School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALPHA 1 ADRENERGIC RECEPTOR; INWARDLY RECTIFYING POTASSIUM CHANNEL; NITRIC OXIDE; ADENOSINE; BARIUM CHLORIDE; BARIUM DERIVATIVE; CHLORIDE; KETOROLAC; N(G) METHYLARGININE; OUABAIN; PROPRANOLOL;

ADRENERGIC ACTIVITY; ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; ENZYME INHIBITION; EXERCISE INTENSITY; FEMALE; FOREARM BLOOD FLOW; FUNCTIONAL SYMPATHOLYSIS; HUMAN; HUMAN EXPERIMENT; MALE; MUSCLE BLOOD FLOW; MUSCLE CONTRACTION; NORMAL HUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; SKELETAL MUSCLE; VASOCONSTRICTION; YOUNG ADULT; ANTAGONISTS AND INHIBITORS; BLOOD FLOW; BRACHIAL ARTERY; CONTROLLED CLINICAL TRIAL; EXERCISE; FOREARM; HAND STRENGTH; PHYSIOLOGY; VASCULARIZATION;

ADENOSINE; ADULT; BARIUM COMPOUNDS; BRACHIAL ARTERY; CHLORIDES; EXERCISE; FEMALE; FOREARM; HAND STRENGTH; HUMANS; KETOROLAC; MALE; MUSCLE CONTRACTION; MUSCLE, SKELETAL; OMEGA-N-METHYLARGININE; OUABAIN; POTASSIUM CHANNELS, INWARDLY RECTIFYING; PROPRANOLOL; RECEPTORS, ADRENERGIC, ALPHA-1; REGIONAL BLOOD FLOW; SODIUM-POTASSIUM-EXCHANGING ATPASE; VASOCONSTRICTION; YOUNG ADULT;

EID: 84931576153     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP270461     Document Type: Article

References (69)

1. Andersen P & Saltin B (1985). Maximal perfusion of skeletal muscle in man. J Physiol 366, 233-249.
2. 2-adrenoceptor constriction to metabolic inhibition during rat skeletal muscle contraction. Circ Res 69, 174-184.
3. Barker JE, Bakhle YS, Anderson J, Treasure T & Piper PJ (1996). Reciprocal inhibition of nitric oxide and prostacyclin synthesis in human saphenous vein. Br J Pharmacol 118, 643-648.
4. Bauersachs J, Popp R, Hecker M, Sauer E, Fleming I & Busse R (1996). Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation 94, 3341-3347.
5. Buckwalter JB & Clifford PS (1999). α-Adrenergic vasoconstriction in active skeletal muscles during dynamic exercise. Am J Physiol 277, H33-H39.
6. Buckwalter JB & Clifford PS (2001). The paradox of sympathetic vasoconstriction in exercising skeletal muscle. Exerc Sport Sci Rev 29, 159-163.
7. 1-Adrenergic-receptor responsiveness in skeletal muscle during dynamic exercise. J Appl Physiol(1985) 85, 2277-2283.
8. Buckwalter JB, Taylor JC, Hamann JJ & Clifford PS (2004). Role of nitric oxide in exercise sympatholysis. J Appl Physiol 97, 417-423.
9. Chavoshan B, Sander M, Sybert TE, Hansen J, Victor RG & Thomas GD (2002). Nitric oxide-dependent modulation of sympathetic neural control of oxygenation in exercising human skeletal muscle. J Physiol 540, 377-386.
10. Crecelius AR, Kirby BS & Dinenno FA (2015). Intravascular ATP and the regulation of blood flow and oxygen delivery in humans. Exerc Sport Sci Rev 43, 5-13.
11. Crecelius AR, Kirby BS, Luckasen GJ, Larson DG & Dinenno FA (2012). ATP-mediated vasodilatation occurs via activation of inwardly-rectifying potassium channels in humans. J Physiol 590, 5349-5359.
12. Crecelius AR, Kirby BS, Luckasen GJ, Larson DG & Dinenno FA (2013). Mechanisms of rapid vasodilatation following a brief contraction in human skeletal muscle. Am J Physiol Heart Circ Physiol 305, H29-H40.
13. Crecelius AR, Kirby BS, Richards JC, Garcia LJ, Voyles WF, Larson DG, Luckasen GJ & Dinenno FA (2011a). Mechanisms of ATP-mediated vasodilation in humans: modest role for nitric oxide and vasodilating prostaglandins. Am J Physiol Heart Circ Physiol 301, H1302-H1310.
14. Crecelius AR, Kirby BS, Voyles WF & Dinenno FA (2010). Nitric oxide, but not vasodilating prostaglandins, contributes to the improvement of exercise hyperemia via ascorbic acid in healthy older adults. Am J Physiol Heart Circ Physiol 299, H1633-H1641.
15. Crecelius AR, Kirby BS, Voyles WF & Dinenno FA (2011b). Augmented skeletal muscle hyperaemia during hypoxic exercise in humans is blunted by combined inhibition of nitric oxide and vasodilating prostaglandins. J Physiol 589, 3671-3683.
16. IR channel activation contributes to onset and steady-state exercise hyperemia in humans. Am J Physiol Heart Circ Physiol 307, H782-H791.
17. Dawes M, Chowienczyk PJ & Ritter JM (1997). Effects of inhibition of the l-arginine/nitric oxide pathway on vasodilation caused by β-adrenergic agonists in human forearm. Circulation 95, 2293-2297.
18. Dinenno FA, Dietz NM & Joyner MJ (2002a). Aging and forearm postjunctional α-adrenergic vasoconstriction in healthy men. Circulation 106, 1349-1354.
19. Dinenno FA, Eisenach JH, Dietz NM & Joyner MJ (2002b). Post-junctional α-adrenoceptors and basal limb vascular tone in healthy men. J Physiol 540, 1103-1110.
20. Dinenno FA & Joyner MJ (2003). Blunted sympathetic vasoconstriction in contracting skeletal muscle of healthy humans: is nitric oxide obligatory? J Physiol 553, 281-292.
21. Dinenno FA & Joyner MJ (2004). Combined NO and PG inhibition augments α-adrenergic vasoconstriction in contracting human skeletal muscle. Am J Physiol Heart Circ Physiol 287, H2576-H2584.
22. Dinenno FA, Masuki S & Joyner MJ (2005). Impaired modulation of sympathetic α-adrenergic vasoconstriction in contracting forearm muscle of ageing men. J Physiol 567, 311-321.
23. Emerson GG & Segal SS (2000). Electrical coupling between endothelial cells and smooth muscle cells in hamster feed arteries: role in vasomotor control. Circ Res 87, 474-479.
24. Faber JE, Harris PD & Joshua IG (1982). Microvascular response to blockade of prostaglandin synthesis in rat skeletal muscle. Am J Physiol 243, H51-H60.
25. Fadel PJ, Farias MIII, Gallagher KM, Wang Z & Thomas GD (2012). Oxidative stress and enhanced sympathetic vasoconstriction in contracting muscles of nitrate-tolerant rats and humans. J Physiol 590, 395-407.
26. Grange RW, Isotani E, Lau KS, Kamm KE, Huang PL & Stull JT (2001). Nitric oxide contributes to vascular smooth muscle relaxation in contracting fast-twitch muscles. Physiol Genomics 5, 35-44.
27. Hartling OJ, Noer I, Svendsen TL, Clausen JP & Trap-Jensen J (1980). Selective and non-selective β-adrenoreceptor blockade in the human forearm. Clin Sci (Lond) 58, 279-286.
28. 2-adrenoreceptor activation. J Physiol 563, 541-555.
29. Hearon CM Jr, Racine ML, Richards JC, Luckasen GJ, Larson DG & Dinenno FA (2014). Increased ATP delivery to contracting skeletal muscle blunts sympathetic vasoconstriction in humans. FASEB J 28, 1172.5. (Abstract)
30. Jackson WF (2005). Potassium channels in the peripheral microcirculation. Microcirculation 12, 113-127.
31. Jantzi MC, Brett SE, Jackson WF, Corteling R, Vigmond EJ & Welsh DG (2006). Inward rectifying potassium channels facilitate cell-to-cell communication in hamster retractor muscle feed arteries. Am J Physiol Heart Circ Physiol 291, H1319-H1328.
32. Johnsson G (1967). The effects of intra-arterially administered propranolol and H 56-28 on blood flow in the forearm-a comparative study of two beta-adrenergic receptor antagonists. Acta Pharmacol Toxicol (Copenh) 25, 63-74.
33. Joyner MJ & Thomas GD (2003). Having it both ways? Vasoconstriction in contracting muscles. J Physiol 550, 333.
34. ATP channel activity augments baroreflex-mediated vasoconstriction in exercising human skeletal muscle. J Physiol 561, 273-282.
35. Kirby BS, Crecelius AR, Richards JC & Dinenno FA (2013a). Sources of intravascular ATP during exercise in humans: critical role for skeletal muscle perfusion. Exp Physiol 98, 988-998.
36. Kirby BS, Crecelius AR, Richards JC, Luckasen GJ, Larson DG & Dinenno FA (2013b). Augmentation of endothelium-dependent vasodilation during mild exercise blunts postjunctional α-adrenergic vasoconstriction. FASEB J 27, 924.9. (Abstract).
37. Kirby BS, Crecelius AR, Voyles WF & Dinenno FA (2011). Modulation of postjunctional α-adrenergic vasoconstriction during exercise and exogenous ATP infusions in ageing humans. J Physiol 589, 2641-2653.
38. Kirby BS, Voyles WF, Carlson RE & Dinenno FA (2008). Graded sympatholytic effect of exogenous ATP on postjunctional α-adrenergic vasoconstriction in the human forearm: implications for vascular control in contracting muscle. J Physiol 586, 4305-4316.
39. Kirby BS, Voyles WF, Simpson CB, Carlson RE, Schrage WG & Dinenno FA (2009). Endothelium-dependent vasodilatation and exercise hyperaemia in ageing humans: impact of acute ascorbic acid administration. J Physiol 587, 1989-2003.
40. Kurjiaka DT & Segal SS (1995). Interaction between conducted vasodilation and sympathetic nerve activation in arterioles of hamster striated muscle. Circ Res 76, 885-891.
41. Lautt WW (1989). Resistance or conductance for expression of arterial vascular tone. Microvasc Res 37, 230-236.
42. Limberg JK, Morgan BJ, Sebranek JJ, Proctor LT, Eldridge MW & Schrage WG (2014). Neural control of blood flow during exercise in human metabolic syndrome. Exp Physiol 99, 1191-1202.
43. Lippton HL, Chapnick BM & Kadowitz PJ (1981). Influence of prostaglandins on vasoconstrictor responses in the hindquarters vascular bed of the cat. Prostaglandins Med 6, 183-202.
44. Markwald RR, Kirby BS, Crecelius AR, Carlson RE, Voyles WF & Dinenno FA (2011). Combined inhibition of nitric oxide and vasodilating prostaglandins abolishes forearm vasodilatation to systemic hypoxia in healthy humans. J Physiol 589, 1979-1990.
45. Marshall RJ, Schirger A & Shepherd JT (1961). Blood pressure during supine exercise in idiopathic orthostatic hypotension. Circulation 24, 76-81.
46. Osanai T, Fujita N, Fujiwara N, Nakano T, Takahashi K, Guan W & Okumura K (2000). Cross talk of shear-induced production of prostacyclin and nitric oxide in endothelial cells. Am J Physiol Heart Circ Physiol 278, H233-H238.
47. Parker BA, Smithmyer SL, Jarvis SS, Ridout SJ, Pawelczyk JA & Proctor DN (2007). Evidence for reduced sympatholysis in leg resistance vasculature of healthy older women. Am J Physiol Heart Circ Physiol 292, H1148-H1156.
48. Pernow J (1988). Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control. Acta Physiol Scand Suppl 568, 1-56.
49. Remensnyder JP, Mitchell JH & Sarnoff SJ (1962). Functional sympatholysis during muscular activity. Observations on influence of carotid sinus on oxygen uptake. Circ Res 11, 370-380.
50. Richards JC, Luckasen GJ, Larson DG & Dinenno FA (2014). Role of α-adrenergic vasoconstriction in regulating skeletal muscle blood flow and vascular conductance during forearm exercise in ageing humans. J Physiol 592, 4775-4788.
51. Rivers RJ, Hein TW, Zhang C & Kuo L (2001). Activation of barium-sensitive inward rectifier potassium channels mediates remote dilation of coronary arterioles. Circulation 104, 1749-1753.
52. 2-adrenergic vasoconstriction is blunted in contracting human muscle. J Physiol 547, 971-976.
53. Rosenmeier JB, Fritzlar SJ, Dinenno FA & Joyner MJ (2003b). Exogenous NO administration and α-adrenergic vasoconstriction in human limbs. J Appl Physiol(1985) 95, 2370-2374.
54. Rosenmeier JB, Hansen J & Gonzalez-Alonso J (2004). Circulating ATP-induced vasodilatation overrides sympathetic vasoconstrictor activity in human skeletal muscle. J Physiol 558, 351-365.
55. Schrage WG, Joyner MJ & Dinenno FA (2004). Local inhibition of nitric oxide and prostaglandins independently reduces forearm exercise hyperaemia in humans. J Physiol 557, 599-611.
56. Seals DR & Victor RG (1991). Regulation of muscle sympathetic nerve activity during exercise in humans. Exerc Sport Sci Rev 19, 313-349.
57. Segal SS (2000). Integration of blood flow control to skeletal muscle: key role of feed arteries. Acta Physiol Scand 168, 511-518.
58. Taddei S, Ghiadoni L, Virdis A, Buralli S & Salvetti A (1999). Vasodilation to bradykinin is mediated by an ouabain-sensitive pathway as a compensatory mechanism for impaired nitric oxide availability in essential hypertensive patients. Circulation 100, 1400-1405.
59. Thomas GD, Hansen J & Victor RG (1994). Inhibition of alpha 2-adrenergic vasoconstriction during contraction of glycolytic, not oxidative, rat hindlimb muscle. Am J Physiol 266, H920-H929.
60. Thomas GD, Hansen J & Victor RG (1997). ATP-sensitive potassium channels mediate contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle. J Clin Invest 99, 2602-2609.
61. Thomas GD, Sander M, Lau KS, Huang PL, Stull JT & Victor RG (1998). Impaired metabolic modulation of α-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. Proc Natl Acad Sci USA 95, 15090-15095.
62. Thomas GD & Victor RG (1998). Nitric oxide mediates contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle. J Physiol 506, 817-826.
63. Torp KD, Tschakovsky ME, Halliwill JR, Minson CT & Joyner MJ (2001). β-Receptor agonist activity of phenylephrine in the human forearm. J Appl Physiol(1985) 90, 1855-1859.
64. Tschakovsky ME, Sujirattanawimol K, Ruble SB, Valic Z & Joyner MJ (2002). Is sympathetic neural vasoconstriction blunted in the vascular bed of exercising human muscle? J Physiol 541, 623-635.
65. VanTeeffelen JW & Segal SS (2003). Interaction between sympathetic nerve activation and muscle fibre contraction in resistance vessels of hamster retractor muscle. J Physiol 550, 563-574.
66. von Kugelgen I & Starke K (1985). Noradrenaline and adenosine triphosphate as co-transmitters of neurogenic vasoconstriction in rabbit mesenteric artery. J Physiol 367, 435-455.
67. Vongpatanasin W, Wang Z, Arbique D, Arbique G, Adams-Huet B, Mitchell JH, Victor RG & Thomas GD (2011). Functional sympatholysis is impaired in hypertensive humans. J Physiol 589, 1209-1220.
68. Winter P & Dora KA (2007). Spreading dilatation to luminal perfusion of ATP and UTP in rat isolated small mesenteric arteries. J Physiol 582, 335-347.
69. Wray DW, Donato AJ, Nishiyama SK & Richardson RS (2007). Acute sympathetic vasoconstriction at rest and during dynamic exercise in cyclists and sedentary humans. J Appl Physiol 102, 704-712.